Möchten Sie immer auf dem neuesten Stand bleiben?

A DEBx Medical está preparada para um crescimento acelerado em soluções para feridas crônicas, com o apoio da segunda rodada de investimento da TVM Capital Healthcare. AMSTERDÃ e DUBAI,...

DEBx Medical ist bereit für ein beschleunigtes Wachstum im Bereich der Lösungen für chronische Wunden, gestützt durch die zweite Investitionsrunde von TVM Capital Healthcare. AMSTERDAM und DUBAI,...

Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Vietnam Pharmaceuticals Market, By Region, By Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...

Sparian Biosciences announced results from the Phase 1 clinical trial of the first in class novel AEAr agonist analgesic SBS-1000.

Io Therapeutics, Inc., presents data on IRX5010 showing inhibition of tumor infiltrating T-cells and myeloid derived suppressor cells in multiple cancers

Positive Phase 1a interim data released for ABI-5366, a long-acting HSV helicase-primase inhibitor candidate for recurrent genital herpes, supporting potential for once-weekly and once-monthly oral...

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "Shock Wave Therapy Device Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global shock...

FLORHAM PARK, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...